Commonwealth Equity Services, LLC Eli Lilly & CO Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 366,244 shares of LLY stock, worth $274 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

366,244

Previous 369,922 0.99%

Holding current value

$274 Million

Previous $335 Million 3.12%

% of portfolio

0.49%

Previous 0.53%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$772.14 - $960.02 $2.84 Million - $3.53 Million	-3,678 Reduced 0.99%	366,244 $324 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $4.8 Million - $6.02 Million	6,621 Added 1.82%	369,922 $335 Million
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $5.17 Million - $6.92 Million	8,736 Added 2.46%	363,301 $283 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $9.17 Million - $10.8 Million	17,461 Added 5.18%	354,565 $207 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $3.15 Million - $4.35 Million	7,254 Added 2.2%	337,104 $181 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $111,886 - $149,604	319 Added 0.1%	329,850 $155 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $5 Million - $5.87 Million	-16,088 Reduced 4.65%	329,531 $113 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $1.49 Million - $1.74 Million	-4,648 Reduced 1.33%	345,619 $126 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $233,626 - $266,241	-788 Reduced 0.22%	350,267 $113 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $4.62 Million - $5.43 Million	16,589 Added 4.96%	351,055 $114 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $678,019 - $842,605	2,889 Added 0.87%	334,466 $95.8 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $1.7 Million - $2.11 Million	7,575 Added 2.34%	331,577 $91.6 Million
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $64,707 - $79,631	292 Added 0.09%	324,002 $74.9 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $5.6 Million - $7.24 Million	31,009 Added 10.59%	323,710 $74.3 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $2.98 Million - $3.86 Million	18,148 Added 6.61%	292,701 $54.7 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $552,889 - $731,605	-4,238 Reduced 1.52%	274,553 $46.4 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $4.82 Million - $5.58 Million	32,997 Added 13.42%	278,791 $41.3 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $827,114 - $995,423	6,063 Added 2.53%	245,794 $40.4 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $72,739 - $90,030	-611 Reduced 0.25%	239,731 $33.3 Million
Q4 2019 Feb 05, 2020	BUY	$106.92 - $132.43 $902,297 - $1.12 Million	8,439 Added 3.64%	240,342 $31.6 Million
Q3 2019 Oct 30, 2019	BUY	$106.79 - $116.16 $25,736 - $27,994	241 Added 0.1%	231,903 $25.9 Million
Q2 2019 Jul 19, 2019	BUY	$110.79 - $129.32 $526,141 - $614,140	4,749 Added 2.09%	231,662 $25.7 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $2.62 Million - $3.08 Million	23,501 Added 11.55%	226,913 $29.4 Million
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $221,966 - $248,669	2,096 Added 1.04%	203,412 $23.5 Million
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $273,464 - $341,782	-3,185 Reduced 1.56%	201,316 $21.6 Million
Q2 2018 Jul 31, 2018	BUY	$75.7 - $86.88 $48,675 - $55,863	643 Added 0.32%	204,501 $17.5 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $321,626 - $379,658	-4,334 Reduced 2.08%	203,858 $15.8 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $17.1 Million - $18.3 Million	208,192	208,192 $17.6 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Eli Lilly & CO Transaction History